When analyzing fibrosis development in the NAFLD-HCC model, we found that 75% of the WT mice fed with WD showed low scores of fibrosis, while 50% of Plin5−/− mice under the same treatment did not develop fibrosis at all. The gene discussed is PLIN5; the disease is metabolic dysfunction-associated steatotic liver disease.